The Fraunhofer USA Center for Molecular Biotechnology ("Fraunhofer CMB") announced today the receipt of a $3.5 million grant from the Bill & Melinda Gates Foundation to support the development of transmission-blocking vaccines against malaria. To achieve the goals of this project, Fraunhofer CMB will employ its proprietary platform technology to produce lifesaving vaccines in non-genetically modified plants. [...] This is the third grant that Fraunhofer CMB has received from the Bill & Melinda Gates Foundation to support development of vaccines using its plant- based platform. A $2.7 million award for development of novel subunit vaccines against influenza was announced last week. Fraunhofer CMB was also the recipient of a $1.2 million Gates Foundation grant in 2005 for pre-clinical studies towards the development of a vaccine against African trypanosomiasis.